Detalhe da pesquisa
1.
Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial.
Int J Cancer
; 153(6): 1241-1250, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37294085
2.
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity.
Cancer Immunol Immunother
; 70(4): 1101-1113, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123754
3.
Survivin promotion of melanoma metastasis requires upregulation of α5 integrin.
Carcinogenesis
; 34(9): 2137-44, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23640047
4.
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators.
J Immunother Cancer
; 9(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589527
5.
Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kß Inhibition in PTEN Loss Melanoma.
Clin Cancer Res
; 25(21): 6406-6416, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371342
6.
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.
Clin Cancer Res
; 24(14): 3366-3376, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29496759
7.
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.
J Natl Cancer Inst
; 110(7): 777-786, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29267866
8.
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.
Cell Metab
; 27(5): 977-987.e4, 2018 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29628419
9.
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes.
Nat Commun
; 8(1): 451, 2017 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28878208
10.
Complementing T-cell Function: An Inhibitory Role of the Complement System in T-cell-Mediated Antitumor Immunity.
Cancer Discov
; 6(9): 953-5, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27587467
11.
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
Cancer Discov
; 6(2): 202-16, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26645196
12.
Role of the apoptotic and mitotic regulator survivin in melanoma.
Anticancer Res
; 32(2): 397-404, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22287725
13.
Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation.
Cancer Res
; 70(20): 7927-37, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20807805